Top 10 Companies in the Southeast Asia Trypsin Market (2026): Market Leaders Powering Regional Biopharma

MARKET INSIGHTS

The Southeast Asia Trypsin market was valued at USD 49.2 million in 2025 and is projected to rise to USD 85 million by 2034, reflecting a compound annual growth rate of 6.3% over the forecast period.

Trypsin is a serine protease that cleaves peptide bonds at the carboxyl side of lysine and arginine residues. Its precision and mild reaction conditions make it indispensable for protein digestion, cell‑culture detachment, and a range of biopharmaceutical processes. The enzyme is sourced from bovine and porcine tissues, with recombinant variants gaining traction in large‑scale production.

Expansion of biopharmaceutical manufacturing—particularly vaccine and monoclonal antibody production—drives demand for high‑purity trypsin. Supply‑chain bottlenecks and regulatory scrutiny of animal‑derived products pose challenges, while recent investments in Singapore’s biomanufacturing hubs and Thailand’s contract research organization sector are fueling new opportunities.

Southeast Asia Trypsin Market – View in Detailed Research Report

---

Top 10 Companies in the Southeast Asia Trypsin Market

1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: High‑purity bovine and porcine trypsin for cell‑culture, biopharmaceutical processing, and research applications

Merck KGaA leverages its extensive bioprocessing facilities in Singapore and Malaysia to supply a consistent, GMP‑grade product line. The company’s robust quality‑management framework ensures batch‑to‑batch reproducibility, a critical requirement for downstream biopharmaceutical workflows.

Sustainability & Growth Initiatives:

• Investment in recombinant trypsin production to reduce reliance on animal sourcing
• Partnerships with local universities to develop next‑generation enzyme formulations
• Adoption of digital traceability systems for supply‑chain transparency

2. Thermo Fisher Scientific

Headquarters: Waltham, USA
Key Offering: Comprehensive portfolio of bovine and porcine trypsin, including recombinant variants, for research and industrial use

Thermo Fisher’s regional distribution network spans Singapore, Thailand, and Vietnam, enabling rapid delivery to biopharma manufacturers and research institutions. The firm’s focus on product innovation is evident in its continuous development of low‑immunogenicity formulations.

Sustainability & Growth Initiatives:

• Expansion of on‑site technical support teams across ASEAN
• Implementation of energy‑efficient manufacturing processes at regional plants
• Strategic alliances with local biotech incubators to co‑develop tailored enzymes

3. Lonza Group

Headquarters: Basel, Switzerland
Key Offering: High‑purity trypsin solutions for cell‑culture, biopharmaceutical processing, and analytical applications

Lonza’s Singapore facility serves as a regional hub for GMP‑grade enzyme production, supporting both contract manufacturing and in‑house biopharma projects. The company’s emphasis on process scalability positions it well to meet the growing demand for recombinant trypsin.

Sustainability & Growth Initiatives:

• Investment in green chemistry protocols for enzyme extraction
• Deployment of advanced analytics to monitor product quality in real time
• Collaborations with ASEAN governments to streamline regulatory approvals

4. Sigma‑Aldrich

Headquarters: St. Louis, USA
Key Offering: Premium bovine trypsin for research and industrial use

Sigma‑Aldrich’s reputation for consistency and purity makes it a preferred supplier for academic laboratories and contract research organizations. The company’s regional logistics network ensures timely delivery across the ASEAN market.

Sustainability & Growth Initiatives:

• Development of recombinant trypsin lines to meet regulatory demands
• Implementation of ISO 14001 environmental management systems at manufacturing sites
• Participation in regional sustainability forums to promote responsible sourcing

5. Novozymes

Headquarters: Bagsværd, Denmark
Key Offering: Specialty protease blends and recombinant trypsin for downstream bioprocessing

Novozymes has introduced proprietary blends that enhance downstream purification and reduce immunogenicity. Its focus on enzyme engineering aligns with the region’s shift toward more efficient bioprocesses.

Sustainability & Growth Initiatives:

• R&D investment in enzyme variants with reduced environmental footprint
• Collaboration with local biotech firms to accelerate product localization
• Commitment to circular economy principles in enzyme production

6. Roche

Headquarters: Basel, Switzerland
Key Offering: Recombinant trypsin and specialty protease solutions for therapeutic development

Roche’s expertise in biologics manufacturing complements its enzyme portfolio, offering integrated solutions for antibody production and cell‑therapy processes.

Sustainability & Growth Initiatives:

• Partnerships with ASEAN research institutes for enzyme co‑development
• Investment in low‑energy bioprocessing technologies
• Adoption of digital platforms for real‑time process monitoring

7. Bio‑Rad Laboratories

Headquarters: Hercules, USA
Key Offering: High‑purity trypsin for research and diagnostic applications

Bio‑Rad’s strong presence in the region is supported by localized technical support and a distribution network that caters to both academic and industrial clients.

Sustainability & Growth Initiatives:

• Development of recombinant enzyme lines to meet regulatory and cost pressures
• Implementation of lean manufacturing practices to reduce waste
• Engagement with local regulators to harmonize approval pathways

8. Thermo‑Scientific Singapore

Headquarters: Singapore
Key Offering: Tailored trypsin formulations for local biopharma and research sectors

Operating from a Singaporean base, Thermo‑Scientific Singapore focuses on delivering rapid, high‑quality enzyme solutions to regional customers, emphasizing local compliance and fast turnaround.

Sustainability & Growth Initiatives:

• Adoption of smart manufacturing to optimize resource use
• Collaboration with local universities for enzyme innovation
• Integration of blockchain for supply‑chain traceability

9. Biochemica

Headquarters: Singapore
Key Offering: Recombinant trypsin for biopharma and analytical use

Biochemica’s niche focus on recombinant enzymes positions it well to serve the growing demand for animal‑free products in the region.

Sustainability & Growth Initiatives:

• Investment in scalable recombinant production platforms
• Partnerships with ASEAN governments to support local manufacturing
• Focus on reducing carbon footprint through energy‑efficient processes

10. GenScript

Headquarters: Singapore
Key Offering: Recombinant trypsin for research and industrial applications

GenScript’s rapid product development cycle and strong digital infrastructure enable it to meet the dynamic needs of the biopharma community.

Sustainability & Growth Initiatives:

• Deployment of AI‑driven design for enzyme optimization
• Collaboration with local biotech incubators for technology transfer
• Commitment to eco‑friendly manufacturing practices

---

Download FREE Sample Report: Southeast Asia Trypsin Market – Sample Report

Get Full Report: Southeast Asia Trypsin Market – Full Report

---

Market Outlook

The Southeast Asia Trypsin market is expected to maintain a steady expansion trajectory, driven by continued investment in biopharmaceutical manufacturing and the adoption of recombinant technology. The shift toward high‑purity, animal‑free enzymes will gradually reshape the supply landscape, positioning companies that can deliver consistent, GMP‑grade products at competitive prices.

Future Trends

• Acceleration of recombinant trypsin production to meet regulatory and cost pressures
• Integration of digital tools for real‑time quality control and supply‑chain visibility
• Expansion of enzyme‑based diagnostics and personalized medicine platforms
• Increased focus on sustainability and circular economy principles in enzyme manufacturing
• Growth of local biomanufacturing clusters driven by supportive government policies